Nationwide Population-based Epidemiological Study of Myasthenia Gravis in Taiwan

Overview

Journal Neuroepidemiology

Specialties Neurology
Public Health

Date 2010 Jun 5

PMID 20523074

Citations 27

Authors

Chien-Hsu Lai

Hung-Fu Tseng

Affiliations

Soon will be listed here.

Abstract

Background: The purpose of this study is to investigate the epidemiology and medical expenses of myasthenia gravis (MG) in Taiwan.

Methods: Cases of MG were identified from the National Health Insurance Research Database with corresponding codes of the International Classification of Diseases, ninth revision (ICD-9), from January 2000 to December 2007. Age- and sex-specific incidences were estimated by dividing the incidence number by population data obtained from the Department of Statistics, Ministry of the Interior.

Results: During the study period, 5,211 cases were identified. The incidence ratio of males to females was 0.68. The average annual incidence rate was 2.1/100,000. MG occurred in all age groups with a higher incidence in older individuals and the lowest incidence in the 10- to 14-year-olds for both sexes. Among the 5,211 cases, 615 (12%) had a neoplasm of the thymus. The prevalence increased steadily during the study period from 8.4/100,000 in 2000 to 14.0/ 100,000 in 2007.

Conclusions: This is the first population-based epidemiological study of MG in Taiwan. The incidence rate and prevalence were higher than in most published studies, especially in old age groups.

Citing Articles

Correlation Between the Prevalence of Myasthenia Gravis and the Frequency of Class II Human Leucocyte Antigen Alleles in Various Geographical Locations Around the World.

Kurian M, Khera N Cureus. 2024; 16(9):e69791.

PMID: 39308848 PMC: 11416033. DOI: 10.7759/cureus.69791.

Epidemiology, Patient Characteristics, and Treatment Patterns of Myasthenia Gravis in Taiwan: A Population-Based Study.

Tsai N, Chien L, Hung C, Kuo A, Chiu Y, Lin H Neurol Ther. 2024; 13(3):809-824.

PMID: 38678112 PMC: 11136923. DOI: 10.1007/s40120-024-00619-4.

The Incidence of Myasthenia Gravis in the Province of Ferrara, Italy, in the Period of 2008-2022: An Update on a 40-Year Observation and the Influence of the COVID-19 Pandemic.

Antonioni A, Raho E, Carlucci D, Sette E, De Gennaro R, Capone J J Clin Med. 2024; 13(1).

PMID: 38202243 PMC: 10780173. DOI: 10.3390/jcm13010236.

The economic burden of individuals living with generalized myasthenia gravis and facing social determinants of health challenges.

Hughes T, Howard Jr J, Silvestri N, Anderson A, Sato M, Suchotliff S Front Public Health. 2023; 11:1247931.

PMID: 37766748 PMC: 10520715. DOI: 10.3389/fpubh.2023.1247931.

The growing burden of generalized myasthenia gravis: a population-based retrospective cohort study in Taiwan.

Herr K, Shen S, Liu Y, Yang C, Tang C Front Neurol. 2023; 14:1203679.

PMID: 37426446 PMC: 10327564. DOI: 10.3389/fneur.2023.1203679.

References

Meriggioli M, Sanders D . Myasthenia gravis: diagnosis. Semin Neurol. 2004; 24(1):31-9. DOI: 10.1055/s-2004-829594. View

STORM-MATHISEN A . Epidemiological and prognostical aspects of myasthenia gravis in Norway. Ann N Y Acad Sci. 1966; 135(1):431-5. DOI: 10.1111/j.1749-6632.1966.tb45491.x. View

Zhang X, Yang M, Xu J, Zhang M, Lang B, Wang W . Clinical and serological study of myasthenia gravis in HuBei Province, China. J Neurol Neurosurg Psychiatry. 2006; 78(4):386-90. PMC: 2077769. DOI: 10.1136/jnnp.2006.100545. View

Vincent A, Newsom-Davis J . Acetylcholine receptor antibody as a diagnostic test for myasthenia gravis: results in 153 validated cases and 2967 diagnostic assays. J Neurol Neurosurg Psychiatry. 1985; 48(12):1246-52. PMC: 1028609. DOI: 10.1136/jnnp.48.12.1246. View

OOSTERHUIS H . The natural course of myasthenia gravis: a long term follow up study. J Neurol Neurosurg Psychiatry. 1989; 52(10):1121-7. PMC: 1031695. DOI: 10.1136/jnnp.52.10.1121. View

Yu Y, Hawkins B, Ip M, Wong V, Woo E . Myasthenia gravis in Hong Kong Chinese. 1. Epidemiology and adult disease. Acta Neurol Scand. 1992; 86(2):113-9. DOI: 10.1111/j.1600-0404.1992.tb05050.x. View

Giagheddu M, Puggioni G, Sanna G, Tamburini G, Marrosu F, Rachele M . Epidemiological study of myasthenia gravis in Sardinia, Italy (1958-1986). Acta Neurol Scand. 1989; 79(4):326-33. DOI: 10.1111/j.1600-0404.1989.tb03793.x. View

Phillips 2nd L, Torner J . Epidemiologic evidence for a changing natural history of myasthenia gravis. Neurology. 1996; 47(5):1233-8. DOI: 10.1212/wnl.47.5.1233. View

Tola M, Caniatti L, Casetta I, Granieri E, Conighi C, Quatrale R . Immunogenetic heterogeneity and associated autoimmune disorders in myasthenia gravis: a population-based survey in the province of Ferrara, northern Italy. Acta Neurol Scand. 1994; 90(5):318-23. DOI: 10.1111/j.1600-0404.1994.tb02731.x. View

10.

Somnier F . Increasing incidence of late-onset anti-AChR antibody-seropositive myasthenia gravis. Neurology. 2005; 65(6):928-30. DOI: 10.1212/01.wnl.0000176067.32186.a3. View

11.

Robertson N, Deans J, Compston D . Myasthenia gravis: a population based epidemiological study in Cambridgeshire, England. J Neurol Neurosurg Psychiatry. 1998; 65(4):492-6. PMC: 2170309. DOI: 10.1136/jnnp.65.4.492. View

12.

Oh S, Kim D, Kuruoglu R, Bradley R, Dwyer D . Diagnostic sensitivity of the laboratory tests in myasthenia gravis. Muscle Nerve. 1992; 15(6):720-4. DOI: 10.1002/mus.880150616. View

13.

Lai C, Tseng H . Population-based epidemiological study of neurological diseases in Taiwan: I. Creutzfeldt-Jakob disease and multiple sclerosis. Neuroepidemiology. 2009; 33(3):247-53. DOI: 10.1159/000229779. View

14.

Matsuda M, Dohi-Iijima N, Nakamura A, Sekijima Y, Morita H, Matsuzawa S . Increase in incidence of elderly-onset patients with myasthenia gravis in Nagano Prefecture, Japan. Intern Med. 2005; 44(6):572-7. DOI: 10.2169/internalmedicine.44.572. View

15.

Thanvi B, Lo T . Update on myasthenia gravis. Postgrad Med J. 2004; 80(950):690-700. PMC: 1743153. DOI: 10.1136/pgmj.2004.018903. View

16.

Phillips 2nd L, Torner J, Anderson M, Cox G . The epidemiology of myasthenia gravis in central and western Virginia. Neurology. 1992; 42(10):1888-93. DOI: 10.1212/wnl.42.10.1888. View

17.

Lavrnic D, Jarebinski M, Rakocevic-Stojanovic V, Stevic Z, Lavrnic S, Pavlovic S . Epidemiological and clinical characteristics of myasthenia gravis in Belgrade, Yugoslavia (1983-1992). Acta Neurol Scand. 1999; 100(3):168-74. DOI: 10.1111/j.1600-0404.1999.tb00733.x. View

18.

Pirskanen R . Genetic aspects in myasthenia gravis. A family study of 264 Finnish patients. Acta Neurol Scand. 1977; 56(5):365-88. View

19.

Oopik M, Kaasik A, Jakobsen J . A population based epidemiological study on myasthenia gravis in Estonia. J Neurol Neurosurg Psychiatry. 2003; 74(12):1638-43. PMC: 1757432. DOI: 10.1136/jnnp.74.12.1638. View

20.

Christensen P, Jensen T, Tsiropoulos I, Sorensen T, Kjaer M, Rasmussen M . Incidence and prevalence of myasthenia gravis in western Denmark: 1975 to 1989. Neurology. 1993; 43(9):1779-83. DOI: 10.1212/wnl.43.9.1779. View